People with Type 2 Diabetes Achieve Superior Outcomes with Insulin Pumps vs. MDI

Status
Not open for further replies.
Northerner

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Comparative Efficacy Results from the OpT2mise Trial Published in The Lancet Could Redefine Management of Insulin-Requiring Type 2 Diabetes

MINNEAPOLIS - July 2, 2014 - As an example of its commitment to improving clinical outcomes for all people with diabetes, Medtronic, Inc. MDT 0.00% today announced the results of the OpT2mise trial, which showed that MiniMed insulin pumps safely achieve better glucose control for people with insulin-requiring type 2 diabetes than multiple daily injections. While the benefits of insulin pump therapy for people with type 1 diabetes are well proven, this is the largest global study to evaluate the comparative efficacy of insulin pump therapy versus multiple daily insulin injections in people with type 2 diabetes with poor glycemic control. Study results were published online in The Lancet today.

http://www.marketwatch.com/story/pe...ly-injections-2014-07-02?reflink=MW_news_stmp
 
Oh - you mean if the results perchance showed they made no difference really they'd have been so happy to publish?

Not that I wish to doubt their veracity of course! :D
 
Status
Not open for further replies.
Back
Top